Perspectives on New Directions in the Management of Postpartum Depression

Perspectives on New Directions in the Management of Postpartum Depression

Perspectives on New Directions in the Management of Postpartum Depression

PPD therapies are offering hope to new mothers. Are you current on the newest class of agents? Tune in to find a rapid response for your patients.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    In this panel discussion, Drs. Anita Clayton, Jennifer Payne, and Nancy Byatt walk us through two clinical cases of postpartum depression.  Listen in as they discuss optimal strategies to screen, diagnosis, and treat patients, as well as go over the newer class of medications specifically targeted at treating PPD.   

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Anita H. Clayton, MD
    Professor and Chair
    Department of Psychiatry & Neurobehavioral Sciences
    University of Virginia School of Medicine
    Charlottesville, VA 

    Contracted Research: Daré Bioscience, Janssen, Relmada Therapeutics, Inc., Sage Therapeutics
    Ownership Interest: Euthymics, Mediflix LLC, S1 Biopharma
    Royalty: Ballantine Books/Random House, Changes in Sexual Function Questionnaire, Guilford Publications
    Consulting Fees: Fabre-Kramer, Janssen Research & Development, LLC, MindCure, Ovoca Bio PLC, PureTech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, Vella Bioscience, Inc, WCG MedAvante-ProPhase

    Nancy Byatt, DO
    Executive Director, Lifeline for Families Center & Lifeline for Moms Program
    Prof. of Psychiatry, Ob-Gyn, and Population & Quantitative Health Sciences
    Medical Director, MCPAP for Moms
    UMass Chan Medical School / UMass Memorial Health Care
    Worcester, MA  

    Consulting Fees: The Kinetix Group, Behavioral Health Network of Excellence

    Jennifer L. Payne, MD
    Professor and Vice Chair of Research
    Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA 

    Consulting Fees: Brii Biosciences, Karuna, PureTech, Sage Therapeutics

    Reviewers/Content Planners/Authors:

    • Nick Lombardi has no relevant financial relationships to report.
    • Libby Lurwick has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Jay Runyon has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Explain how the mechanisms of action of approved and emerging agents for postpartum depression help alleviate symptoms of the condition
    • Discuss the efficacy and safety findings from clinical trials of approved and emerging therapies for postpartum depression
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians, gynecologists, psychiatrists, and primary care physicians; nurse practitioners and physician assistants in each of those specialty areas.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative (GLC) designates this activity for 15 minutes of nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 
    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Sage Therapeutics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free